Jul 2 |
Vertex Announces FDA Acceptance of New Drug Application for Vanzacaftor/Tezacaftor/Deutivacaftor, a Next-In-Class Triple Combination Treatment for Cystic Fibrosis
|
Jul 2 |
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
|
Jul 1 |
Vertex to Announce Second Quarter 2024 Financial Results on August 1
|
Jul 1 |
3 Breakout Biotech Stocks on Track to Double by 2032
|
Jul 1 |
Bull Market Buys: 2 Growth Stocks to Own for the Long Run
|
Jun 29 |
Insider Sale at Vertex Pharmaceuticals Inc (VRTX): EVP and CMO Carmen Bozic Sells 2,280 Shares
|
Jun 28 |
2 Superior Growth Stocks to Buy if You Have $1,000 Right Now
|
Jun 28 |
Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030
|
Jun 28 |
2 Healthcare Stocks That Are Screaming Buys in June
|
Jun 27 |
You’ve Been Warned! 3 Biotech Stocks to Buy Now or Regret Forever.
|